Explore

Trendline Trendline
Iambic to Engage Investors at Upcoming Healthcare and Technology Conferences

Iambic to Engage Investors at Upcoming Healthcare and Technology Conferences

Iambic to Engage Investors at Upcoming Healthcare and Technology Conferences
Trendline Trendline
AI and Biotechnology Convergence Drives Personalized Medicine Advancements

AI and Biotechnology Convergence Drives Personalized Medicine Advancements

AI and Biotechnology Convergence Drives Personalized Medicine Advancements
Trendline Trendline
Almirall's European Dermatology Business Drives Q1 2026 Growth

Almirall's European Dermatology Business Drives Q1 2026 Growth

Almirall's European Dermatology Business Drives Q1 2026 Growth
Trendline Trendline
Travere Therapeutics to Present at Major Investor Conferences, Highlighting Rare Disease Focus

Travere Therapeutics to Present at Major Investor Conferences, Highlighting Rare Disease Focus

Travere Therapeutics to Present at Major Investor Conferences, Highlighting Rare Disease Focus
Trendline Trendline
Immunai Expands Collaboration with AstraZeneca in $37.5 Million Deal

Immunai Expands Collaboration with AstraZeneca in $37.5 Million Deal

Immunai Expands Collaboration with AstraZeneca in $37.5 Million Deal
Trendline Trendline
AbCellera to Present at Major Investor Conferences in May and June 2026

AbCellera to Present at Major Investor Conferences in May and June 2026

AbCellera to Present at Major Investor Conferences in May and June 2026
Trendline Trendline
Kanvas Biosciences Secures $48 Million to Advance Microbiome-Based Cancer Therapies

Kanvas Biosciences Secures $48 Million to Advance Microbiome-Based Cancer Therapies

Kanvas Biosciences Secures $48 Million to Advance Microbiome-Based Cancer Therapies
Trendline Trendline
Bio-Rad Laboratories to Engage in Key Investor Conferences Highlighting Financial Strategies

Bio-Rad Laboratories to Engage in Key Investor Conferences Highlighting Financial Strategies

Bio-Rad Laboratories to Engage in Key Investor Conferences Highlighting Financial Strategies
Trendline Trendline
Exelixis to Webcast Fireside Chats at Upcoming Investor Conferences in May 2026

Exelixis to Webcast Fireside Chats at Upcoming Investor Conferences in May 2026

Exelixis to Webcast Fireside Chats at Upcoming Investor Conferences in May 2026
Trendline Trendline
Exelixis to Webcast Fireside Chats at Major Investor Conferences in May 2026

Exelixis to Webcast Fireside Chats at Major Investor Conferences in May 2026

Exelixis to Webcast Fireside Chats at Major Investor Conferences in May 2026
Trendline Trendline
Arrowhead Pharmaceuticals Reports Strong Fiscal 2026 Second Quarter Results Amid Expanding RNAi Therapeutics

Arrowhead Pharmaceuticals Reports Strong Fiscal 2026 Second Quarter Results Amid Expanding RNAi Therapeutics

Arrowhead Pharmaceuticals Reports Strong Fiscal 2026 Second Quarter Results Amid Expanding RNAi Therapeutics
Trendline Trendline
Bio-Rad Laboratories to Engage in Key Investor Conferences, Highlighting Financial Strategies

Bio-Rad Laboratories to Engage in Key Investor Conferences, Highlighting Financial Strategies

Bio-Rad Laboratories to Engage in Key Investor Conferences, Highlighting Financial Strategies